Articles by Tyler Menichiello

  1. Evaluating The Levers Driving Productivity In Bioprocessing 8/28/2026

    Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."

  2. Overcoming Recovery Challenges In AAV Production 8/26/2026

    Siren Biotechnology's SVP of vector development, Nathalie Clément, Ph.D., explains the challenge of purifying AAV capsids and the ways developers are optimizing vector recovery.

  3. Preserving Tacit Knowledge In ADC Tech Transfers 8/19/2026

    ADCs built on proprietary platforms risk losing process-specific knowledge during a tech transfer. See what advice panelists from the Bioprocess Online Live event "Ensuring Successful Technology Transfer In ADC Development" shared with the audience on preserving this implicit knowledge.

  4. 08.11.26 -- June 2026 — CDMO Opportunities And Threats Report 8/11/2026

    08/11/26

  5. Multispecific Manufacturability Starts With Molecular Design 7/21/2026

    AP Biosciences’ VP of antibody discovery, Jhong-Jhe You, Ph.D., explains the key design elements of multispecific antibodies and how they affect product developability.

  6. On The Ground At BIO 2026: Johanna Kaufmann, Ph.D., On The Oncology Modality Puzzle 7/10/2026

    At the 2026 BIO International Convention, Bioprocess Online caught up with Johanna Kaufmann, Ph.D., CSO at Deck Bio, a company developing multi-targeted T-cell engagers for solid tumors.

  7. BIO 2026: Modernizing The FDA And Bolstering The Workforce 7/10/2026

    Bioprocess Online's chief editor, Tyler Menichiello, shares his key takeaways from the 2026 BIO International Convention in San Diego.

  8. BIO 2026: Crowley On Competing With China And Modernizing The FDA 7/8/2026

    Exclusive coverage from John Crowley's press conference at the 2026 BIO International Convention in San Diego.

  9. Essential CMC Elements For A Therapeutic Secretome 6/30/2026

    Noveome Biotherapeutics's Larry Brown, Sc.D., explains the regulatory and CMC challenges behind the company's novel secretome therapy, ST266.

  10. Midyear Pulse Check: What's Shaping Biopharma In 2026? 6/16/2026

    This article summarizes the major developments and industry pressures highlighted by Life Science Connect editors in the "Better Biopharma" midyear editorial roundtable.